Carle Cancer Institute is a clinical research site located in Urbana, Illinois, United States 61801.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
Carle Cancer Institute has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung.
Sponsors: Washington University School of Medicine, Genprex, Inc., BriaCell Therapeutics Corporation.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Carle Cancer Institute has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Carle Cancer Institute has 3 clinical trials on record, with 2 currently active. Their work covers Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung.
Carle Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.